We are delighted to announce our support for research focussed charitable organisation, St Pauls Research Foundation in its efforts to prevent and treat sight loss. This agreement will see Cambridge Spectacle Co commit profits on an ongoing basis to fund long-term research into eye disease.
The partnership has been formed as a practical manifestation of our mission to help the world see better. Founded by an Optometrist and dedicated to improving patient lives, Cambridge Spectacle Co believes it has a fundamental responsibility to help eradicate blindness and take care of the planet’s sight.
Charitable work has been a key facet of St. Paul’s activity since it was established as a small hospital in 1871. Since then it has grown to become an internationally renowned organisation funding pioneering research to cure eye disease and prevent sight-loss not only in the UK, but world-wide.
St Paul’s research covers areas including age related macular degeneration (amd), and stem cell research where new retinal cells are grown and implanted into the eye in order to replace those damaged through ageing.
“On behalf of us all here at St Paul's Eye Unit, we can’t thank Cambridge Spectacle enough for their support of our charity”, said Tom Southern, Director of Fundraising at St Paul's Eye Research Foundation.
"The support of Cambridge Spectacle Co. comes at an important time for us as we recover our position after a very difficult two years by launching our new appeal later this year that will change the way we detect, diagnose and treat eye disease for the next 10 to 20 years”, he added.
“We are thrilled to be able to support St Paul’s Eye Unit and the Clinical Eye Research Centre”, said Ahmed Ejaz, Chief Executive at Cambridge Spectacle Co. “The team is undertaking novel approaches in tackling eye disease and we are pleased to be able to play a part in their world-class research.
Cambridge Spectacle Co was founded with a mission to help prevent eye disease across the globe and we feel strongly that backing our world class institutions in the UK is key in achieving this.
The pandemic has had far reaching effects across our industry and charities have had a tough time in finding funding for their work. We must not forget that funding research now will have a long term benefit beyond the pandemic and enable our future generations to live in a world where we can be free of preventable eye disease.”